Pacific SCD | Upcoming Webinar: CA Sickle Cell Disease Longitudinal Data Collection Project
17301
single,single-post,postid-17301,single-format-standard,ajax_fade,page_not_loaded,,qode-theme-ver-7.8,wpb-js-composer js-comp-ver-4.3.5,vc_responsive

Upcoming Webinar: CA Sickle Cell Disease Longitudinal Data Collection Project

22 Dec Upcoming Webinar: CA Sickle Cell Disease Longitudinal Data Collection Project

CALIFORNIA-RARE-DISEASE-SURVEILLANCE-PROGRAM

Save the date for an upcoming webinar:
Wed., January 27, 10-11 PST (1-2 EST) for the
CA Sickle Cell Disease Longitudinal Data Collection Project

 

CLICK HERE: Read/Download full report “Paulukonis SCD Longitudinal Data Collection”

Save Wednesday, January 27, 10-11 PST for our next quarterly webinar featuring Dr. James Eckman, MD, Professor Emeritus of Hematology and Medical Oncology
Emory University School of Medicine.Below is the link for an updated version of the project report mentioned during our webinar on November 9, 2015: Longitudinal Data Collection for Sickle Cell Disease in California: History, Goals and Challenges

For those who were not able to attend all or part of our introductory webinar, we have also attached the slides and have  provided the recording (requires brief registration): https://attendee.gotowebinar.com/recording/4696245430197965058.

California’s new SCD longitudinal data collection system project is a follow-up and expansion to the RuSH and PHRESH surveillance programs conducted in the state beginning in 2010.

November’s introductory webinar was the first in a series of quarterly webinars that will provide featured speakers and project updates.  We will send the link to register for the next webinar early next year.   Please feel free to send any questions or comments to faith.raider@cdph.ca.gov

 

The California Rare Disease Surveillance Program is a part of the California Environmental Health Tracking Program and the Public Health Institute.

The Sickle Cell Disease Longitudinal Data Collection System project in California is made possible through funding support from Pfizer, Inc. and Biogen to the CDC Foundation.

No Comments

Sorry, the comment form is closed at this time.